Statistical haemoglobin thresholds to define anaemia across the lifecycle

Competing Interest Statement

S-RP reports role as consultant for CSL Vifor and roles as Head (WHO Collaborating Centre for Anaemia Detection and Control) and as co-Chair (Guideline Development Group Meetings for WHO haemoglobin thresholds to define anaemia in clinical medicine and public health). All other authors declare no competing interests.

Funding Statement

The analysis was funded by the World Health Organization and the Bill and Melinda Gates Foundation (INV-050676). SP is funded by NHMRC GNT2009047. MB is funded by NHMRC GNT1195236. This work was also supported by the Victorian Government's Operational Infrastructure Support Program and the NHMRC Independent Research Institute Infrastructure Support Scheme (IRIISS). Funding to support TARGet Kids! was provided by multiple sources including the Canadian Institutes for Health Research (CIHR), the Hospital for Sick Children Foundation, Toronto, Canada, and the St. Michael's Hospital Foundation, Toronto, Canada. The funders had no role in the planning, analysis or decision to publish this work. Genes & Health has recently been core-funded by the Wellcome Trust (WT102627, WT210561), the Medical Research Council (UK) (M009017), Higher Education Funding Council for England Catalyst, Barts Charity (845/1796), Health Data Research UK (for London substantive site), and research delivery support from the NHS National Institute for Health Research Clinical Research Network (North Thames). This research uses data from China Health and Nutrition Survey (CHNS). We are grateful to research grant funding from the National Institute for Health (NIH), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) for R01 HD30880 and R01 HD38700, National Institute on Aging (NIA) for R01 AG065357, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) for R01 DK104371 and P30 DK056350, National Heart, Lung, and Blood Institute (NHLBI) for R01 HL108427, the NIH Fogarty grant D43 TW009077, the Carolina Population Center for P2C HD050924 and P30 AG066615 since 1989, and the China-Japan Friendship Hospital, Ministry of Health for support for CHNS 2009, Chinese National Human Genome Center at Shanghai since 2009, and Beijing Municipal Center for Disease Prevention and Control since 2011.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Study data used for this analysis are either publicly available or were accessed with agreement from primary data collection sources, and will not be available from the study authors.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes